PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA
Clinical trials for PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy tested for Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether combining two drugs, durvalumab and lurbinectedin, can help control cancer growth in people with extensive stage small cell lung cancer that has come back or stopped responding to their first treatment. The trial aims to see if this combination can k…
Matched conditions: PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo aims to outsmart tough lung cancer
Disease control OngoingThis study is testing if adding an experimental drug called berzosertib (M6620) to standard chemotherapy (topotecan) works better than chemotherapy alone for adults whose small cell lung cancer has come back. The goal is to see if the combination can help control the cancer for l…
Matched conditions: PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test Triple-Threat attack on Tough-to-Treat lung cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a new three-drug combination for small cell lung cancer that has returned after initial treatment. The combination includes a pill (tazemetostat), a chemotherapy (topotecan), and an immunotherapy (pembrolizumab), aimin…
Matched conditions: PLATINUM-RESISTANT LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC